User banner image
User avatar
  • admin

Posts

LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation

GAITHERSBURG, Md., Sept. 27, 2024 /PRNewswire/ — LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (“LakeShore Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering,...

Yocan Introduces Hit 2: The Ultimate Device for Vaping Enthusiasts

Shenzhen, China, Sept. 26, 2024 (GLOBE NEWSWIRE) — Yocan proudly announces the launch of the Yocan Hit 2, a cutting-edge vaporizer designed for discerning vaping enthusiasts. This innovative...

BASE CAMP Dust Mask Launches Cotton Cloth Face Mask with a Vision for a Healthier Future

The BASE CAMP Cotton Face Mask, with its 4D design, provides a snug fit and effective filtration, making it a great dust mask for everyday...

Conversational AI Market Size Worth $39.55 Billion, Globally, by 2031 – Exclusive Report by The Insight Partners

The conversational AI market size is expected to reach US$ 39.55 billion by 2031 from US$ 8.45 billion in 2023 to record a CAGR of...

ibex Jamaica Holds Back-To-School Event to Support Children of Employees

Students received laptops, tablets, backpacks, school supplies and bookstore gift vouchers for the new school year PORTMORE, Jamaica, Sept. 26, 2024 (GLOBE NEWSWIRE) — ibex...

Boutique West Coast Redefined: Sooke Harbour House Showcases Extensive Renovations

Iconic Vancouver Island Resort and Restaurant Reopen SOOKE, British Columbia, Sept. 26, 2024 (GLOBE NEWSWIRE) — Sooke Harbour House today announced its grand reopening after...

Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic...

Cassava Sciences Resolves SEC Investigation

AUSTIN, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (“Cassava” or the “Company”) (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today...

Humacyte to Host Virtual KOL Event to Discuss Case Studies on the Use of Acellular Tissue Engineered Vessel (ATEV™) in Vascular Trauma Treatment on September 30, 2024

DURHAM, N.C., Sept. 26, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial...

Streamline Health® Announces 1-For-15 Reverse Stock Split

ATLANTA, Sept. 26, 2024 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (NASDAQ: STRM), a leading provider of solutions that enable healthcare...